HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cheorl-Ho Kim Selected Research

phorbol

1/2019Esculentoside H inhibits colon cancer cell migration and growth through suppression of MMP-9 gene expression via NF-kB signaling pathway.
2/2008Secretion of atherogenic risk factor apolipoprotein B-100 is increased by a potential mechanism of JNK/PKC-mediated insulin resistance in liver cells.
4/2007Lactosylceramide alpha2,3-sialyltransferase is induced via a PKC/ERK/CREB-dependent pathway in K562 human leukemia cells.
3/2005Molecular mechanism for transcriptional activation of ganglioside GM3 synthase and its function in differentiation of HL-60 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cheorl-Ho Kim Research Topics

Disease

66Neoplasms (Cancer)
09/2021 - 03/2003
23Atherosclerosis
08/2021 - 05/2003
19Neoplasm Metastasis (Metastasis)
01/2019 - 12/2002
16Inflammation (Inflammations)
01/2022 - 08/2003
14Hepatocellular Carcinoma (Hepatoma)
09/2014 - 07/2002
12Breast Neoplasms (Breast Cancer)
04/2020 - 08/2004
12Bone Resorption
04/2008 - 02/2002
11Arthritis (Polyarthritis)
04/2015 - 07/2003
8Carcinogenesis
12/2013 - 10/2003
7Infections
01/2021 - 12/2002
7Colonic Neoplasms (Colon Cancer)
01/2019 - 02/2006
7Rheumatoid Arthritis
05/2013 - 07/2004
6Lung Neoplasms (Lung Cancer)
08/2020 - 01/2014
6BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2020 - 11/2004
6Leukemia
12/2018 - 01/2004
6Alzheimer Disease (Alzheimer's Disease)
06/2006 - 08/2003
5Hypoxia (Hypoxemia)
12/2018 - 09/2004
5Carcinoma (Carcinomatosis)
07/2018 - 10/2004
5Osteosarcoma (Osteogenic Sarcoma)
09/2017 - 10/2006
5Hypersensitivity (Allergy)
01/2017 - 02/2005
5Neuroblastoma
08/2016 - 12/2003
5Hepatitis B
06/2014 - 12/2002
5Melanoma (Melanoma, Malignant)
10/2013 - 11/2007
5Fibrosis (Cirrhosis)
04/2012 - 05/2004
4Stomach Neoplasms (Stomach Cancer)
05/2021 - 01/2004
4Hypertension (High Blood Pressure)
05/2021 - 01/2005
4Anaphylaxis (Anaphylactic Shock)
01/2017 - 04/2005
4Glioblastoma (Glioblastoma Multiforme)
02/2016 - 06/2006
4Experimental Arthritis
12/2008 - 07/2004
4Osteoporosis
07/2006 - 08/2003
4Pheochromocytoma
03/2006 - 06/2004
3Glioma (Gliomas)
12/2015 - 06/2006
3Metabolic Bone Diseases (Osteopenia)
01/2008 - 12/2004
3Autoimmune Thyroiditis (Lymphomatous Thyroiditis)
02/2007 - 08/2004

Drug/Important Bio-Agent (IBA)

20Matrix Metalloproteinases (MMPs)IBA
03/2018 - 03/2003
18Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2003
15CytokinesIBA
01/2022 - 08/2003
13Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2019 - 12/2002
8AntioxidantsIBA
01/2021 - 05/2003
8Bee Venoms (Bee Venom)IBA
01/2019 - 12/2006
8EnzymesIBA
12/2015 - 07/2002
7CholesterolIBA
09/2021 - 05/2003
7N-Acetylneuraminic Acid (Sialic Acid)IBA
07/2020 - 08/2004
7G(M3) GangliosideIBA
01/2018 - 07/2006
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2015 - 08/2003
6LipopolysaccharidesIBA
01/2022 - 02/2004
6ascochlorinIBA
07/2019 - 07/2005
6NF-kappa B (NF-kB)IBA
01/2019 - 11/2004
6Cathepsin KIBA
04/2008 - 11/2003
5LectinsIBA
01/2022 - 11/2004
5Biological ProductsIBA
01/2021 - 10/2012
5Anti-Bacterial Agents (Antibiotics)IBA
07/2019 - 09/2008
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2017 - 03/2009
5GangliosidesIBA
01/2017 - 08/2004
5Collagen Type II (Type II Collagen)IBA
04/2015 - 07/2003
5Therapeutic UsesIBA
10/2006 - 10/2004
4Transcription Factor AP-1 (Transcription Factor AP 1)IBA
01/2022 - 03/2007
4Triglycerides (Triacylglycerol)IBA
09/2021 - 10/2006
4Anti-Allergic Agents (Antiallergic Agents)IBA
05/2021 - 12/2011
4Epidermal Growth Factor (EGF)IBA
08/2020 - 01/2013
4Pharmaceutical PreparationsIBA
03/2019 - 05/2003
4phorbolIBA
01/2019 - 03/2005
4CaspasesIBA
12/2018 - 01/2013
4Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2018 - 02/2005
4haematoside synthetaseIBA
01/2018 - 01/2004
4GlycosphingolipidsIBA
09/2017 - 08/2004
4Methanol (Carbinol)IBA
01/2017 - 02/2005
4Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2017 - 01/2010
4Apolipoproteins B (ApoB)IBA
01/2017 - 06/2004
4Biomarkers (Surrogate Marker)IBA
01/2017 - 05/2004
4Peptides (Polypeptides)IBA
04/2015 - 12/2003
4Melitten (Melittin)IBA
04/2015 - 01/2013
4caffeic acid phenethyl esterIBA
08/2014 - 11/2004
4DNA (Deoxyribonucleic Acid)IBA
06/2014 - 10/2004
4Transforming Growth Factor beta (TGF-beta)IBA
05/2009 - 08/2003
4Dinoprostone (PGE2)FDA Link
06/2008 - 08/2004
4Free RadicalsIBA
02/2008 - 06/2004
4CollagenIBA
03/2007 - 07/2004
3Polysaccharides (Glycans)IBA
01/2022 - 10/2004
3Interleukin-6 (Interleukin 6)IBA
01/2021 - 11/2004
3ascofuranoneIBA
08/2020 - 09/2008
3Antineoplastic Agents (Antineoplastics)IBA
07/2019 - 03/2011
3AntigensIBA
01/2019 - 05/2004
3Protein Glutamine gamma Glutamyltransferase 2IBA
09/2017 - 11/2004
3IsothiocyanatesIBA
09/2017 - 06/2005
3SialyltransferasesIBA
01/2017 - 06/2006
3p38 Mitogen-Activated Protein KinasesIBA
02/2016 - 03/2006
3Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
03/2012 - 11/2004
3Plant ExtractsIBA
12/2011 - 03/2004
3Interleukin-1beta (Interleukin 1 beta)IBA
05/2009 - 02/2002
3alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferaseIBA
08/2008 - 11/2004
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
06/2008 - 02/2004
3Cysteine Proteases (Cysteine Protease)IBA
04/2008 - 11/2003
3FlavonoidsIBA
02/2008 - 06/2005
3Anabolic AgentsIBA
01/2008 - 12/2004
3ThyroglobulinFDA Link
02/2007 - 08/2004

Therapy/Procedure

7Oral Administration
01/2019 - 08/2003
7Therapeutics
01/2018 - 02/2004
4East Asian Traditional Medicine (Oriental Medicine)
02/2007 - 01/2005
3Traditional Medicine (Folk Remedies)
01/2017 - 07/2005